Threshold Pharmaceuticals Announces Presentation and Webcast at the Stifel Healthcare Conference 2016
November 15 2016 - 4:05PM
Threshold Pharmaceuticals, Inc. (Nasdaq:THLD), a clinical-stage
biopharmaceutical company developing novel therapies for cancer,
today announced that Barry Selick, Ph.D., Threshold's Chief
Executive Officer, will be presenting at the Stifel Healthcare
Conference on November 16, 2016, at 8:00 a.m. Eastern Time. A live
audio webcast of the presentation will be available in the
“Investors” section of Threshold’s website, www.thresholdpharm.com.
A replay of the presentation will be archived for 30 days following
the conference.
About Threshold Pharmaceuticals Threshold is a
clinical-stage biopharmaceutical company focused on the development
of drugs and diagnostic agents targeting the tumor microenvironment
of solid tumors and hematologic malignancies. This approach offers
broad potential to treat a variety of cancers. By selectively
targeting tumor cells, we are building a pipeline of drugs that
hold promise to be more effective and less toxic to healthy tissues
than conventional anticancer drugs. For additional information,
please visit the Company’s website.
Contact:
Denise Powell
denise@redhousecomms.com
510.703.9491
Molecular Templates (NASDAQ:MTEM)
Historical Stock Chart
From Mar 2024 to Apr 2024
Molecular Templates (NASDAQ:MTEM)
Historical Stock Chart
From Apr 2023 to Apr 2024